Pharmaceuticals face 100% tariffs in US – unless firms strike a deal
This is a significant and potentially disruptive policy shift, indicating a strong move by the US administration to exert pressure on certain parts of the pharmaceutical industry. Let’s break down the implications: 1. **What’s Affected:** * **Branded/Patented Medicines:** The 100% tariffs would apply to *non-generic* pharmaceuticals imported into the US. This typically includes innovative, high-cost
Pharmaceuticals face 100% tariffs in US – unless firms strike a deal Read More »
Economy